Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
|
CN |
|
Emetals Ltd
ASX:EMT
|
AU |
|
M
|
Michlol Finance Ltd
TASE:MCLL
|
IL |
|
Companhia de Eletricidade do Estado da Bahia Coelba
BOVESPA:CEEB3
|
BR |
|
Materialise NV
NASDAQ:MTLS
|
BE |
|
Abrau-Durso PAO
MOEX:ABRD
|
RU |
|
Jones Soda Co
OTC:JSDA
|
US |
|
G
|
Greencoat Renewables PLC
ISEQ:GRP
|
IE |
|
Hatten Land Ltd
SGX:PH0
|
SG |
|
China Citic Bank Corp Ltd
SSE:601998
|
CN |
Dividends
Dividend Yield
Henan Taloph Pharmaceutical Stock Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Henan Taloph Pharmaceutical Stock Co Ltd
Henan Taloph Pharmaceutical Stock Co Ltd have
decreased
by 0%.
Payout Ratio
Henan Taloph Pharmaceutical Stock Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Henan Taloph Pharmaceutical Stock Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Henan Taloph Pharmaceutical Stock Co Ltd
| Average Annual Return | 1.89% |
| Standard Deviation of Annual Returns | 39.5% |
| Max Drawdown | -61% |
| Market Capitalization | 4.1B CNY |
| Shares Outstanding | 573 890 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Henan Taloph Pharmaceutical Stock Co Ltd's latest stock split occurred on May 12, 2010
The company executed a 13-for-10 stock split, meaning that for every 10 shares held, investors received 13 new shares.
The adjusted shares began trading on May 12, 2010. This was Henan Taloph Pharmaceutical Stock Co Ltd's 3rd stock split, following the previous one in Jun 3, 2008.
